Description:GLP-1 (9-36) amide is a peptide derived from the glucagon-like peptide-1 (GLP-1), which plays a crucial role in glucose metabolism and appetite regulation. This specific fragment, which is an amide form, is produced through the enzymatic cleavage of the full-length GLP-1. It is characterized by its ability to interact with GLP-1 receptors, albeit with a different potency and efficacy compared to its longer counterparts. The peptide is known to exhibit various biological activities, including the modulation of insulin secretion and the inhibition of glucagon release, contributing to its potential therapeutic applications in diabetes management. The CAS number 161748-29-4 uniquely identifies this compound, which is relevant in research settings across multiple species, including humans, bovines, guinea pigs, mice, porcine, and rats. Its stability, solubility, and bioactivity make it a subject of interest in pharmacological studies aimed at understanding metabolic disorders and developing related treatments.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
